FDA Adverse Event Injury Summary report: N

TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 2992925 · Received March 7, 2013

Report

Report Number
2134265-2013-01297
Event Type
Injury
Date Received
March 7, 2013
Date of Event
September 12, 2010
Report Date
February 13, 2013
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

(B)(4). SAME PATIENT AS 2134265-2013-01296. IT WAS REPORTED THAT DURING A CORONARY STENTING TREATMENT PROCEDURE THE PATIENT EXPERIENCED REPERFUSION DYSRHYTHMIA. THE TARGET LESION WAS LOCATED IN THE DISTAL RIGHT CORONARY ARTERY (DIST RCA) WITH 100% STENOSIS AND WAS 40 MM LONG WITH A REFERENCE VESSEL DIAMETER OF 3.5 MM. THE PHYSICIAN TREATED THE LESION WITH PRE-DILATATION AND PLACEMENT OF A 3.50 X 16 MM TAXUS LIBERTE STENT DISTALLY OVERLAPPING WITH 3.00 X 38 MM TAXUS LIBERTE STENT. FOLLOWING POST DILATATION, THE RESIDUAL STENOSIS WAS 10%. DURING THE INDEX PROCEDURE, POST DEPLOYMENT OF THE TAXUS LIBERTE STENTS, THE PATIENT EXPERIENCED REPERFUSION DYSRHYTHMIA'S WITH BRADYCARDIA, HYPOTENSION, NAUSEA AND INCREASE IN CHEST PAIN. THE PATIENT WAS TREATED WITH MEDICATIONS WHICH RESOLVED OVER TIME. THE PATIENT WAS DISCHARGED ON ASPIRIN AND PRASUGREL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
97673 TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE UNK433

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention 3.50X16MM TAXUS LIBERTE STENT